Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
Clinical trial NCT06431633 · RECRUITING
Trial details
- NCT number
- NCT06431633
- Sponsor
- Fundación GECP
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-04
- Primary completion
- 2031-11-30
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.